Redi.1.AsCas12a-L218S-I285S-L972A
(Plasmid
#235234)
-
PurposeExpresses reduced immunogenicity variant of AsCas12a (Redi.1.AsCas12a) with mutations L218S, I285S, L972A.
-
Depositing Lab
-
Sequence Information
Ordering
| Item | Catalog # | Description | Quantity | Price (USD) | |
|---|---|---|---|---|---|
| Plasmid | 235234 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $94 | |
Backbone
-
Vector backbonepcDNA3.1
- Backbone size w/o insert (bp) 5354
- Total vector size (bp) 9464
-
Vector typeMammalian Expression, CRISPR
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)NEB Stable
-
Copy numberUnknown
Gene/Insert
-
Gene/Insert namehAsCpf1
-
Alt nameAsCas12a
-
SpeciesAcidaminococcus_sp_BV3L6
-
Insert Size (bp)3921
- Promoter CMV
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site KpnI (not destroyed)
- 3′ cloning site EcoRI (not destroyed)
- 5′ sequencing primer CMV-F
- 3′ sequencing primer BGH-rev
- (Common Sequencing Primers)
Resource Information
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
Redi.1.AsCas12a-L218S-I285S-L972A was a gift from Feng Zhang (Addgene plasmid # 235234 ; http://n2t.net/addgene:235234 ; RRID:Addgene_235234) -
For your References section:
Rational engineering of minimally immunogenic nucleases for gene therapy. Raghavan R, Friedrich MJ, King I, Chau-Duy-Tam Vo S, Strebinger D, Lash B, Kilian M, Platten M, Macrae RK, Song Y, Nivon L, Zhang F. Nat Commun. 2025 Jan 2;16(1):105. doi: 10.1038/s41467-024-55522-1. 10.1038/s41467-024-55522-1 PubMed 39747875